0001193125-22-150105.txt : 20220513 0001193125-22-150105.hdr.sgml : 20220513 20220513161657 ACCESSION NUMBER: 0001193125-22-150105 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220512 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eargo, Inc. CENTRAL INDEX KEY: 0001719395 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 273879804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39616 FILM NUMBER: 22922947 BUSINESS ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 650-351-7700 MAIL ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 8-K 1 d342354d8k.htm 8-K 8-K
false 0001719395 0001719395 2022-05-12 2022-05-12

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 12, 2022

 

 

EARGO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39616   27-3879804

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

2665 North First Street, Suite 300

San Jose, California

   95134
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (650) 351-7700

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered:

Common Stock, $0.0001 par value per share   EAR   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 12, 2022, Eargo, Inc. (the “Company”) received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it remains delinquent in filing its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 and its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and because it is delinquent in filing its Quarterly Report on Form 10-Q for the three months ended March 31, 2022, it has not regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission.

Previously, Nasdaq had granted the Company an extension until May 16, 2022 to regain compliance. The Letter indicated that the Company’s securities would be subject to delisting on May 23, 2022 as a result of the Company’s non-compliance, unless on or before May 19, 2022 the Company requests a hearing before the Nasdaq Hearings Panel (the “Panel”) and requests an extended stay of suspension or delisting.

The Company intends to timely request a hearing before the Panel, at which hearing it will present its plan to regain compliance and request the continued listing of its securities on Nasdaq pending its return to compliance. Such request will automatically stay any suspension or delisting action by Nasdaq for a period of 15 days from the date of the Company’s request. The stay may be extended at the option of the Panel upon the Company’s request and support of such extension, and the Company intends to ask the Panel for a further stay concurrent with its request for a hearing and pending the ultimate conclusion of the hearing process.

Item 7.01. Regulation FD Disclosure.

A press release, dated May 13, 2022, disclosing the Company’s receipt of the Letter referenced above is attached hereto as Exhibit 99.1.

The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.   

Description

99.1    Eargo, Inc. Press Release, dated May 13, 2022.
104    Cover Page Interactive File, formatted in Inline XBRL.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this report are forward-looking statements, including statements regarding the Company’s intended requests of the Panel and related Panel proceedings. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks, uncertainties and assumptions related to: completion of the Company’s financial closing procedures for the periods ended September 30, 2021, December 31, 2021 and March 31, 2022 and any adjustments that may result from the completion of the annual independent audit of its consolidated financial statements; the extent to which the Company may be able to validate and establish processes to support the submission of claims for reimbursement from the Federal Employee Health Benefits program in the future, if at all, and the Company’s ability to maintain or increase insurance coverage of its hearing aids; the timing or results of ongoing claims audits and medical records

reviews by third-party payors; the extent of losses from hearing aids delivered to customers from September 21, 2021 until December 8, 2021; the Company’s ability to regain compliance with Nasdaq Listing Rules; the Company’s ability to raise capital on acceptable terms, if at all; the impact of the U.S. Department of Justice investigation, third-party payor audits and the regulatory landscape for hearing aid devices on the Company’s business and results of operations; the Company’s expectations concerning additional orders by existing customers; the Company’s expectations regarding the potential market size and size of the potential consumer populations for its products and any future products; the Company’s ability to release new hearing aids and the anticipated features of any such hearing aids; developments and projections relating to the Company’s competitors and industry, including competing products; the Company’s ability to maintain its competitive technological advantages against new entrants in its industry; the pricing of the Company’s hearing aids; the Company’s expectations regarding the ability to make certain claims related to the performance of its hearing aids relative to competitive products; and the Company’s estimates regarding the COVID-19 pandemic, including but not limited to, its duration and its impact on the Company’s business and results of operations. These and other risks are described in greater detail under the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission. Any forward-looking statements in this Current Report on Form 8-K are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, are based on current expectations, forecasts and assumptions, and speak only as of the date of this report. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 13, 2022     EARGO, INC.
    By:  

/s/ Adam Laponis

      Adam Laponis
      Chief Financial Officer
 EX-99.1 2 d342354dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Eargo Announces Receipt of Nasdaq Non-Compliance Letter

SAN JOSE, CA. May 13, 2022 – Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it remains delinquent in filing its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 and its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and because it is delinquent in filing its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, it has not regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission.

Previously, Nasdaq had granted the Company an extension until May 16, 2022 to regain compliance. The Letter indicated that the Company’s securities would be subject to delisting on May 23, 2022 as a result of the Company’s non-compliance, unless on or before May 19, 2022 the Company requests a hearing before the Nasdaq Hearings Panel (the “Panel”) and requests an extended stay of suspension or delisting.

The Company intends to timely request a hearing before the Panel, at which hearing it will present its plan to regain compliance and request the continued listing of its securities on Nasdaq pending its return to compliance. Such request will automatically stay any suspension or delisting action by Nasdaq for a period of 15 days from the date of the Company’s request. The stay may be extended at the option of the Panel upon the Company’s request and support of such extension, and the Company intends to ask the Panel for a further stay concurrent with its request for a hearing and pending the ultimate conclusion of the hearing process.

About Eargo

Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated, exempt Class I or Class II devices indicated to compensate for mild to moderate hearing. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo device is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Eargo’s sixth generation device, Eargo 6, is an FDA, Class II exempt hearing device featuring Sound Adjust technology that automatically optimizes the soundscape as the user moves between environments. Eargo 6 is available for purchase here.

Related Links

http://eargo.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this report are forward-looking statements, including statements regarding the Company’s intended requests of the Panel and related Panel proceedings. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks, uncertainties and assumptions related to: completion of the Company’s financial closing procedures for the periods ended September 30, 2021, December 31, 2021 and March 31, 2022 and any adjustments that may result from the completion of the annual independent audit of its consolidated financial statements; the extent to which the Company may be able to validate and establish processes to support the submission of claims for reimbursement from the Federal Employee Health Benefits program in the future, if at all, and the Company’s ability to maintain or increase insurance coverage of its hearing aids; the timing or results of ongoing claims audits and medical records reviews by third-party payors; the extent of losses from hearing aids delivered to customers from September 21, 2021 until December 8, 2021; the Company’s ability to regain compliance with Nasdaq Listing Rules; the Company’s ability to raise capital on acceptable terms, if at all; the impact of the U.S. Department of Justice investigation, third-party payor audits and the regulatory landscape for hearing aid devices on the Company’s business and results of operations; the Company’s expectations concerning additional orders by existing customers; the Company’s expectations regarding the potential market size and size of the potential consumer populations for its products and any future products; the Company’s ability to release new hearing aids and the anticipated features of any such hearing aids; developments and projections relating to the Company’s competitors and industry, including competing products; the Company’s ability to maintain its competitive technological advantages against new entrants in its industry; the pricing of the Company’s hearing aids; the Company’s expectations regarding the ability to make certain claims related to the performance of its hearing aids relative to competitive products; and the Company’s estimates regarding the COVID-19 pandemic, including but not limited to, its duration and its impact on the Company’s business and results of operations. These and other risks are described in greater detail under the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission. Any forward-looking statements in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, are based on current expectations, forecasts and assumptions, and speak only as of the date of this release. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact

Nick Laudico

Senior Vice President of Corporate Strategy and Investor Relations

ir@eargo.com

EX-101.SCH 3 ear-20220512.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 ear-20220512_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 ear-20220512_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g342354g0513110822749.jpg GRAPHIC begin 644 g342354g0513110822749.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
May 12, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001719395
Document Type 8-K
Document Period End Date May 12, 2022
Entity Registrant Name EARGO, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-39616
Entity Tax Identification Number 27-3879804
Entity Address, Address Line One 2665 North First Street
Entity Address, Address Line Two Suite 300
Entity Address, City or Town San Jose
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95134
City Area Code (650)
Local Phone Number 351-7700
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol EAR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 d342354d8k_htm.xml IDEA: XBRL DOCUMENT 0001719395 2022-05-12 2022-05-12 false 0001719395 8-K 2022-05-12 EARGO, INC. DE 001-39616 27-3879804 2665 North First Street Suite 300 San Jose CA 95134 (650) 351-7700 false false false false Common Stock, $0.0001 par value per share EAR NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( !J"K50'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " :@JU4BD5.DNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R'%H#R;-I:.G#@8K;.QF;+4UBQ-C:R1]^SE>FS*V!]C1TN]/ MGT"-]E(/ 9_#X#&0Q?@PN:Z/4OL-.Q-Y"1#U&9V*94KTJ7D<@E.4GN$$7ND/ M=4(0G*_!(2FC2,$,+/Q"9&UCM-0!%0WABC=ZP?O/T&68T8 =.NPI0E56P-IY MHK],70-WP PC#"Y^%] LQ%S]$YL[P*[)*=HE-8YC.=8YEW:HX.UI_Y+7+6P? M2?4:TZ]H)5T\;MAM\FN]?3SL6"NX$ 5?%55]$%Q6:[D2[[/K#[^[L!N,/=I_ M;'P3;!OX=1?M%U!+ P04 " :@JU4F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M !J"K536;]P,1P0 -T0 8 >&PO=V]R:W-H965T&UL MG9C?<^(V$,>?KW^%ANE#.Y/$MOA]0Y@A)+G2NQ ::&^FG3X(6X FMN23Y #_ M?5>&V/1JUDQ?@F1KO_YHM=J5,M@J_6HVG%NR2V)I;AL;:]./GF?"#4^8N5$I ME_!FI73"+'3UVC.IYBS*C9+8H[[?\1(F9&,XR)_-]'"@,AL+R6>:F"Q)F-[? M\5AM;QM!X_W!BUAOK'O@#0WC5'P\8ZV MG4$^X@_!M^:D3=Q4EDJ]NLXDNFWXCHC'/+1.@L'/&Q_S.'9*P/'M*-HHOND, M3]OOZH_YY&$R2V;X6,5?160WMXU>@T1\Q;+8OJCM+_PXH1PP5+')_Y+M86S+ M;Y P,U8E1V,@2(0\_++=T1&G!O2, 3T:T)S[\*&<\IY9-AQHM27:C08UU\BG MFEL#G)!N5>96PUL!=G9XK\(,G&P)DQ%YD%;8/9G(PVJ#UP:>A8^XH5YX%+P[ M"-(S@D]L3P)Z1:A/Z;^M/4 K^&C!1W.YYAFYL7KCFOPU6AJK807_1B2;A60S MEVR=D1S!?*-\SH\Q6U?-$+=?L=APA*-5<+10G:.WQT"B60Q>C_B.?.;[*B)< MR??]H!OTF_TV@M4NL-JH6!$1BWW*JUAP\][U9P2B4T!T+H.8<2V4B\R(0'Q7 M\N!*QWC\X<.'FHCL%FC=2Y;MA:^%BTE@G+*D$JQ&9_3RZ?F*3*;C&X2J5U#U M+J&:R%#I5.E\\Y*Y!9>1L\$'80G\,NTYU]"M& [,HD@T,1*A >GG>>KD:3=ZV:OV^_Y+8SP M)#$'EQ".HDAS8Z[>&^0+C"//LG(I:R1II],F4Z7M!I9"&PL!HJ%P8+AEG@[H M_\==;%4E+BXYSP2$;]/W,< RZP=XVOX><.QZ2I.%VE:7.5QNSB3Y5:&%("@K M07!1*2C8#AL7X&9:O0D95B\VKCD>86AE-0CP?/X]VDP9"]7J3Y&>32@UBOUV MT$2W2%DD CRWYTLX@L/H>11LYNII,*%ZLX[05D% CR%SU4L0F&%7),G M"' M6%S)@ZO4\="R"% \8\\TS]W#88<=CCQP,H3CYO-J5;U^-7JU9&7RIWBF M_@_9Q)@,R&H!<=E:P)-C>4UNYF&FW?8+Z)(LA(TKMU^-B)MA?DQ1X>L5^=&_ M<0=9DC)-WEB<<9+"5,V&:12Y+ 4S]@+S2(7>O-]LE25@5&PO9KEMWDOSAR+DCO9*ZW="C<\W[ M)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3 M;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@ M:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_& M%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V M_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUS MS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D M^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>P MSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0 M_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^& M<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8 M[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( !J"K527BKL< MP !," + 7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$ M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:GH_ 0 / ( \ !X;"]W;W)K8F]O:RYX;6R-49:EL@9OTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+ MD6M#V743&4K&& 3L@!W".?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+ M)+S$P,9M2XK.%7HR#'9 C.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\ M@2P/73>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0 M ( !J"K50D'INBK0 /@! : >&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&R MGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0 MDBBZ0=@S9)[NF:*'3^ 5!+ M P04 " :@JU499!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX M;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85- MK'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+ MY8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE# MVQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/) MW55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_ ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( !J"K50'04UB@0 +$ 0 M " 0 !D;V-0&UL4$L! A0#% @ &H*M M5(I%3I+N *P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% @ &H*M5)E&PO=V]R:W-H965T&UL4$L! A0#% @ &H*M5)^@&_"Q @ X@P T ( ! MB@P 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL M4$L! A0#% @ &H*M5"0>FZ*M ^ $ !H ( !NQ$ M 'AL+U]R96QS+W=O9(9 0 SP, !, ( !H!( %M#;VYT96YT7U1Y<&5S72YX 8;6Q02P4& D "0 ^ @ ZA, end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d342354d8k.htm d342354dex991.htm ear-20220512.xsd ear-20220512_lab.xml ear-20220512_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d342354d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d342354d8k.htm" ] }, "labelLink": { "local": [ "ear-20220512_lab.xml" ] }, "presentationLink": { "local": [ "ear-20220512_pre.xml" ] }, "schema": { "local": [ "ear-20220512.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ear", "nsuri": "http://eargo.com/20220512", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d342354d8k.htm", "contextRef": "duration_2022-05-12_to_2022-05-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d342354d8k.htm", "contextRef": "duration_2022-05-12_to_2022-05-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://eargo.com//20220512/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001193125-22-150105-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-150105-xbrl.zip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